skip to main
|
skip to sidebar
U.S. STOCK MARKETS
TRANSLATOR
Selasa, 20 April 2010
GERDAU AMERISTEEL (NYSE)
Gerdau Ameristeel, apakah membentuk triple top ? dengan target harga 8.4
Tidak ada komentar:
Posting Komentar
Posting Lebih Baru
Posting Lama
Beranda
Langganan:
Posting Komentar (Atom)
Label
AAR CORP
(1)
ABBOTT
(1)
ACETO
(1)
ADOLOR
(1)
ADTRAN
(1)
AETERNA ZENTARIS
(1)
AGNICO EAGLE
(1)
AKAMAI TECHNOLOGY
(1)
AKON
(1)
ALBANY MOLECULAR
(1)
ALCOA
(1)
ALLIED HEALTHCARE
(1)
ALTAIR NANO
(1)
ALTERA
(1)
AMBAC FINANCIAL
(1)
AMERCAN ELECTRIC
(1)
AMERiCAN ELECTRIC
(1)
ANTIGENICS
(1)
ARBA
(1)
ARENA PHARMA
(1)
ATMEL CORP
(1)
AVON
(1)
BLOCKBUSTER
(1)
BP
(1)
BRISTOL MYER
(1)
CADENCE DESIGN
(1)
CHINA INFRA
(1)
CISCO
(1)
CITI
(1)
CONOLOG CORP
(1)
CORINTHIAN
(1)
CSUN
(1)
DARA BIOSCIENCE
(1)
DISCOVERY LAB
(2)
DJI
(1)
FIRST SOLAR
(1)
GERDAU AMERISTEEL
(1)
GOLDMAN SACHS
(1)
GOODYEAR
(1)
HELIOS BIOSCIENCE
(1)
KEYCORP
(1)
KIMBERLY
(1)
LEGG MASON
(1)
NAVISTAR
(1)
NOKIA
(1)
OMNICARE
(1)
PALM
(1)
PARKER VISION
(1)
PDL BIOPHARMA
(1)
PFIZER
(2)
RANGOLD RESOURCES
(1)
SANDISK
(1)
SEMPRA ENERGY
(1)
SILICONEWARE
(1)
SOUTH FINANCI
(1)
SUNPOWER
(1)
TIBCO SOFTWARE
(1)
VALERO ENERGY
(1)
WALLMART
(1)
ZIONS
(1)
Arsip Blog
▼
2010
(62)
►
Juli
(1)
►
Juni
(7)
►
Mei
(10)
▼
April
(29)
SEMPRA ENERGY (NYSE)
AGNICO EAGLE MINE (NYSE)
DARA BIOSCIENCE (NASDAQ)
CHINA INFRA (NASDAQ)
ALTAIR NANO TECHNOLOGY (NASDAQ)
GOLDMAN SACHS (NYSE)
PFIZER (NYSE)
SUNPOWER (NASDAQ)
CONOLOG CORPORATION (NASDAQ)
GERDAU AMERISTEEL (NYSE)
BLOCKBUSTER (NYSE)
CADENCE DESIGN (NASDAQ)
ADOLOR (NASDAQ)
AETERNA ZENTARIS (NASDAQ)
GOODYEAR (NYSE)
AAR CORP (NYSE)
HELIOS BIOSCIENCE (NASDAQ)
DISCOVERY LAB (NASDAQ)
ANTIGENIC (NASDAQ)
PALM
AMBAC FINANCIAL (NYSE)
CHINA SUNERGY (NASDAQ)
ARIBA (NASDAQ)
KEYCORP (NYSE)
AMAERICAN ELECTRIC (NYSE)
SOUTH FINANCI (NASDAQ)
TIBCO SOFTWARE (NASDAQ)
OMNICARE (NYSE)
LEGG MASON (NYSE)
►
Maret
(1)
►
Januari
(14)
LIVE TRAFFIC
Feedjit Live Blog Stats
VISITORS
Get your
free hit counter
at EZWebsiteCounter.com.
Pengikut
Mengenai Saya
Unknown
Lihat profil lengkapku
Tidak ada komentar:
Posting Komentar